List of works - Masatoshi Ishigami

Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis

scientific article published on 23 July 2008

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy

scientific article published on 23 June 2011

Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness

scientific article published on January 2015

Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy

scientific article

Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFN alpha-2b

scientific article published in March 2009

Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan

scientific article published in April 2007

Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders

scientific article published on 14 November 2012

Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease

scientific article published on 30 October 2019

Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93.

scientific article published on 7 November 2017

Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

scientific article published on February 2015

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

scientific article published in November 2007

Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

scientific article published on 12 June 2009

Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.

scientific article published in July 2007

Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma

scientific article published on 22 December 2019

Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy

scientific article published on 30 July 2018

Lewis Score on Capsule Endoscopy can Predict the Prognosis in Patients with Small Bowel Lesions of Crohn's Disease

scientific article published on 07 December 2020

Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV.

scientific article

Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy

scientific article published on March 2009

Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B.

scientific article published on 29 January 2013

Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus

scientific article published on 27 July 2015

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains

scientific article published on 13 January 2010

Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single‐nucleotide polymorphism of interleukin‐28B with the response to combination therapy with pegylated‐interferon‐alpha 2b and ribavirin ⬇️

scientific article published on March 1, 2012

Revisiting the indications for liver transplantation in cirrhotic patients considering the long-term outcomes of cirrhotic patients

scientific article published on 05 June 2020

Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease

scientific article published on 21 August 2019

Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus eradication

scientific article published on 03 June 2018

The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC

scientific article published on 20 October 2020

The relationship between oral-origin bacteria in the fecal microbiome and albumin bilirubin grade in patients with hepatitis C

scientific article published on 03 August 2020

Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients

scientific article published on 18 September 2018

List of works by Masatoshi Ishigami